返回
healthcare: pharma新闻
为你推荐
市场
经济
科技与人工智能
加密货币
能源
医疗保健
港股与中国
金融与地产
制药
生物技术
卫生服务
医疗器械
BioMarin beats Q2 estimates, lifts 2026 outlook on 20% revenue growth
Aug 07 2026, 17:08
TransThera shares jump 14% on China approval of tinengotinib
Aug 07 2026, 03:35
FDA approves Replimune's Tudriqev melanoma drug after two rejections
Aug 07 2026, 03:25
Hikma jumps 10% as H1 profit beats, brokers keep buy
Aug 06 2026, 10:06
BeOne Medicines lifts 2026 outlook as Brukinsa sales jump 31%
Aug 06 2026, 05:28
Moderna wins FDA approval for mFLUSIVA flu vaccine in adults 50+
Aug 06 2026, 02:49
FDA approves Takeda's oveporexton, first orexin agonist for narcolepsy type 1
Aug 05 2026, 22:16
Lilly raises 2026 guidance as Mounjaro, Zepbound drive 48% revenue jump
Aug 05 2026, 11:41
Gilead Q2 revenue jumps 10% as PrEP sales top $1 billion
Aug 05 2026, 02:48
Novo Nordisk raises 2026 outlook after Q2 profit jumps 11%
Aug 04 2026, 16:54
CRISPR Therapeutics narrows Q2 loss as Casgevy sales surge 151%
Aug 04 2026, 16:19
Merck raises 2026 sales forecast to $67.3B, cuts profit view
Aug 04 2026, 11:16
Regeneron faces securities suit after $11 billion melanoma trial wipeout
Aug 04 2026, 01:21
Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination
Aug 03 2026, 14:23
Ascletis starts Phase III obesity trial enrolling 4,600 patients
Aug 03 2026, 13:58
AstraZeneca, Bristol Myers Squibb in talks on $400 billion merger
Aug 03 2026, 07:50
Sandoz settles $450 million antitrust claims with 43 US states
Aug 03 2026, 06:25
Novo Nordisk claws back into obesity race as shares climb 35%
Aug 03 2026, 05:51
FDA approves Novartis Pluvicto, cutting prostate cancer progression risk 33%
Jul 31 2026, 23:48
Pharming shares plunge 22% as RUCONEST sales slide 10%
Jul 31 2026, 22:45
功能特性
股票与加密货币 AI 助手
价格预测
筹款追踪器
加密货币比较
首页
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
使用条款
隐私政策
站点地图
© 2026 Edgen 由
